Media about us

  • 12 February 2018

    A new training center will be established in NovaMedica Innotech

    A new training center will be established in NovaMedica Innotech

    GMP News

    NovaMedica, a Russian pharmaceutical company and the investment project of RUSNANO, has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company and a leader in the global market of excipients for pharmaceutical industry.

  • 02 February 2018

    Syndax entered a clinicial trial collaboration with AstraZeneca

    Syndax entered a clinicial trial collaboration with AstraZeneca

    GMP News

    Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced a new clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca’s durvalumab.

  • 02 February 2018

    AstraZeneca, Syndax ally to test PD-L1 drug and CSF1R inhibitor in solid tumor patients

    AstraZeneca, Syndax ally to test PD-L1 drug and CSF1R inhibitor in solid tumor patients

    Nick Paul Taylor / FierceBiotech

    AstraZeneca and Syndax have teamed up to test immune checkpoint inhibitor Imfinzi in combination with CSF1R inhibitor SNDX-6352. Syndax is set to put the cocktail through a phase 1b solid tumor trial to equip both companies to sponsor midphase trials to demonstrate its safety and efficacy.

  • 23 January 2018

    Blockchain as a technology goes far beyond cryptocurrency application. Interview with Maxim Gorbachev, Managing Partner at RMI Partners

    Blockchain as a technology goes far beyond cryptocurrency application. Interview with Maxim Gorbachev, Managing Partner at RMI Partners

    #WBSMoscow

    As the blockchain revolution gains momentum around the world, Trescon had the opportunity to interview Maxim Gorbachev, a Managing Partner at RMI Partners, on the evolving nature of blockchain. RMI Partners is a venture capital company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies.

  • 22 January 2018

    Russia grants Hermes GMP certification at German and Austrian plants

    Russia grants Hermes GMP certification at German and Austrian plants

    Dan Stanton / In-Pharma Technologist.com

    Since 2011, Russian policy has favoured local production in e􀃗orts to reduce reliance on pharmaceutical imports. Vladimir Putin’s ‘Pharma 2020’ policy pushes for as much 90% of drugs consumed in Russia to be made domestically by 2020. Such policies have led multinationals to tap the market through collaborations with domestic drugmakers. Pfizer, for example, teamed with Russian pharma firm NovaMedica last May to build an aseptic manufacturing plant in.

  • 19 January 2018

    Start Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device

    Start Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device

    Catherine Longworth / MedTech Insight

    Israeli start up OCON Medical is blazing a trail in the field of women's health with a new hormone-free contraceptive device. The company's IUB – intrauterine ball consists of copper pearls that prevent pregnancy locally within the uterus for five years.

  • 11 January 2018

    Genentech, Syndax expand HDAC-PD-L1 combination pact

    Genentech, Syndax expand HDAC-PD-L1 combination pact

    Nick Paul Taylor / FierceBiotech

    Genentech and Syndax have expanded their exploration of the effects of combining HDAC and PD-L1 inhibitors. The new agreement clears the Roche subsidiary to test its Tecentriq in combination with Syndax’s entinostat in a subset of breast cancer patients.

  • 28 December 2017

    NovaMedica Innotech R&D center meets Russian GMP standards

    NovaMedica Innotech R&D center meets Russian GMP standards

    GMP News

    NovaMedica, a Russian pharmaceutical company and investment project of RUSNANO, announced that it received the conclusion of the Russian Ministry of Industry and Trade on the compliance of the production site of NovaMedica Innotech R&D center, a subsidiary of NovaMedica, with the Russian Good Manufacturing Practice (GMP) standards.

  • 26 December 2017

    Authorities approve the application of NovaMedica for a new production facility

    Authorities approve the application of NovaMedica for a new production facility

    GMP News

    NovaMedica, a Russian pharmaceutical company and investment project of RUSNANO, announced that it received the approval of the Inter-Agency Commission for conclusion of Special Investment Contract (SPIC) under the investment project aimed at establishing a pharmaceutical plant for sterile injectable drugs in the Kaluga region.

  • 11 December 2017

    An Epic quest to detect cancer

    An Epic quest to detect cancer

    Bradley J. Fikes / The San-Diego Union Tribune

    Finding needles in a haystack is the life-and-death job of San Diego’s Epic Sciences. The needles are extremely rare cancer cells that hide among the millions of normal cells in the blood of cancer patients.

All Portfolio

MEDIA CENTER

  • NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the start of construction of a plant for the production of sterile injectable drugs as part of its long-term strategy to localize innovative medicines and technologies of their development and production in Russia. The plant will be built in the industrial park “Vorsino” in the Kaluga region.

All news